Explore more publications!
Arkansas Healthcare Report
Got News to Share?

Arkansas Healthcare Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Arkansas Healthcare Report.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 16, 2025

Trethera Receives $2.7 Million NIH Grant, Validating the Potential of First-in-Class TRE-515 to Overcome KRAS Inhibitor Resistance in Lung Cancer
December 16, 2025

Trethera Receives $2.7 Million NIH Grant, Validating the Potential of First-in-Class TRE-515 to Overcome KRAS Inhibitor Resistance in Lung Cancer

Indeterminate GlobeNewswire
Canada’s food and agriculture sector takes centre stage in Saskatoon with Plant Forward on the Prairies
December 16, 2025

Canada’s food and agriculture sector takes centre stage in Saskatoon with Plant Forward on the Prairies

Indeterminate GlobeNewswire
Secai’s Voxira Becomes the First Medical AI Voice Agent Certified by the Quebec Ministry of Health
December 16, 2025

Secai’s Voxira Becomes the First Medical AI Voice Agent Certified by the Quebec Ministry of Health

Indeterminate GlobeNewswire
Voxira de Secai devient la première secrétaire médicale en intelligence artificielle certifiée par le ministère de la Santé du Québec
December 16, 2025

Voxira de Secai devient la première secrétaire médicale en intelligence artificielle certifiée par le ministère de la Santé du Québec

Indeterminate GlobeNewswire
Cellution Biologics Inc. Announces First Peer-Reviewed Publication Demonstrating Positive Outcomes for AmchoPlast™ in the Treatment of Chronic Diabetic Foot Ulcers
December 16, 2025

Cellution Biologics Inc. Announces First Peer-Reviewed Publication Demonstrating Positive Outcomes for AmchoPlast™ in the Treatment of Chronic Diabetic Foot Ulcers

Indeterminate GlobeNewswire
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
December 16, 2025

Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era

Indeterminate GlobeNewswire
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
December 16, 2025

Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era

Indeterminate GlobeNewswire
WEIGHT WATCHERS LANCE UNE PLATEFORME COMPLÈTE POUR LES TRAITEMENTS GLP-1
December 16, 2025

WEIGHT WATCHERS LANCE UNE PLATEFORME COMPLÈTE POUR LES TRAITEMENTS GLP-1

Indeterminate GlobeNewswire
WEIGHT WATCHERS LANCEERT EEN VOLLEDIG GEÏNTEGREERD PLATFORM VOOR HET GLP-1-TIJDPERK
December 16, 2025

WEIGHT WATCHERS LANCEERT EEN VOLLEDIG GEÏNTEGREERD PLATFORM VOOR HET GLP-1-TIJDPERK

Indeterminate GlobeNewswire
Weight Watchers Lanceert Een Volledig Geïntegreerd Platform Voor Het Tijdperk Van Gewichtsgerelateerde Gezondheid
December 16, 2025

Weight Watchers Lanceert Een Volledig Geïntegreerd Platform Voor Het Tijdperk Van Gewichtsgerelateerde Gezondheid

Indeterminate GlobeNewswire
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
December 16, 2025

Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era

Indeterminate GlobeNewswire
Halo Pharma Enhances Manufacturing Capabilities with Macro-Pactor® Investment
December 16, 2025

Halo Pharma Enhances Manufacturing Capabilities with Macro-Pactor® Investment

Indeterminate GlobeNewswire
Weight Watchers lance une plateforme entièrement intégrée pour une nouvelle ère de santé liée au poids
December 16, 2025

Weight Watchers lance une plateforme entièrement intégrée pour une nouvelle ère de santé liée au poids

Indeterminate GlobeNewswire
WEIGHT WATCHERS (VIKTVÄKTARNAS MODERBOLAG) LANSERAR EN NY INTEGRERAD PLATTFORM FÖR GLP-1
December 16, 2025

WEIGHT WATCHERS (VIKTVÄKTARNAS MODERBOLAG) LANSERAR EN NY INTEGRERAD PLATTFORM FÖR GLP-1

Indeterminate GlobeNewswire
YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center
December 16, 2025

YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center

Indeterminate GlobeNewswire
J-Star Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
December 16, 2025

J-Star Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Indeterminate GlobeNewswire
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
December 16, 2025

Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era

Indeterminate GlobeNewswire
Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan
December 16, 2025

Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan

Indeterminate GlobeNewswire
Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100
December 16, 2025

Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100

Indeterminate GlobeNewswire
Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in Locally Advanced Pancreatic Cancer
December 16, 2025

Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in Locally Advanced Pancreatic Cancer

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions